By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted August 7, 2019APYX MEDICAL CORPORATION REPORTS SECOND QUARTER AND FIRST HALF OF 2019 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2019 OUTLOOK READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted August 6, 2019APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF MINNIE BAYLOR-HENRY TO THE COMPANY’S BOARD OF DIRECTORS READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted August 5, 2019APYX MEDICAL CORPORATION RECEIVES 510(K) CLEARANCE FOR NEXT-GENERATION J-PLASMA® PRECISE HANDPIECE DESIGNED FOR LAPAROSCOPIC SURGERY READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted July 31, 2019APYX MEDICAL CORPORATION ANNOUNCES NEW ADDITIONS TO CLINICAL AND REGULATORY AFFAIRS TEAMS READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted July 15, 2019APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF FOUR MEMBERS TO ITS MEDICAL ADVISORY BOARD READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted July 2, 2019APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON AUGUST 7, 2019 READ MORE
By apyxmedical In 2018 Shareholder News, 2019 Shareholder News, J-Plasma, RenuvionPosted July 1, 2019APYX MEDICAL CORPORATION JOINS RUSSELL 3000® AND RUSSELL 2000® INDEXES READ MORE
By apyxmedical In 2018 Shareholder News, 2019 Shareholder News, J-Plasma, RenuvionPosted June 4, 2019APYX MEDICAL CORPORATION TO PARTICIPATE IN THE JMP SECURITIES LIFE SCIENCES CONFERENCE READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted May 8, 2019APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2019 OUTLOOK READ MORE
By apyxmedical In 2019 Shareholder News, J-Plasma, RenuvionPosted April 1, 2019APYX MEDICAL CORPORATION PROVIDES UPDATE ON THE PREMARKET NOTIFICATION 510(K) SUBMISSION TO THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR USE IN DERMAL RESURFACING PROCEDURES; PROVIDES PRELIMINARY FIRST QUARTER 2019 REVENUE RESULTS AND REAFFIRMS 2019 REVENUE OUTLOOK READ MORE
